<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-63-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-8-10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Learning and Behavior Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Food-Induced Hyperkinesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>08</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>8</issue>
<fpage>63</fpage>
<lpage>64</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/0140-6736(92)90742-L" vol="339" page="1150">
<article-title>Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The results of a controlled trial of hyposensitization with intradermal EPD (beta-glucuronidase and food antigens) in 40 children with the hyperkinetic syndrome are reported from the Universitatskinderklinik, Lindwurmstrasse, Munchen, Germany and The Allergy Unit, London, UK.</p>
</abstract>
<kwd-group>
<kwd>Food-Induced Hyperkinetic Syndrome</kwd>
<kwd>Hyposensitization</kwd>
<kwd>Pharmacological Therapy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The results of a controlled trial of hyposensitization with intradermal EPD (beta-glucuronidase and food antigens) in 40 children with the hyperkinetic syndrome are reported from the Universitatskinderklinik, Lindwurmstrasse, Munchen, Germany and The Allergy Unit, London, UK. The study was in 3 phases: the first consisted of the oligoantigenic diet; children who responded to the diet entered the reintroduction of foods, phase II; and those with food-induced hyperkinetic syndrome entered phase III, a double-blind, placebo-controlled trial of EPD, 3 intradermal doses at 2-monthly intervals. Of 20 patients who received the hyposensitization active treatment, 16 became tolerant toward provoking foods, compared with 4 of 20 who received placebo (p&#x003C;0.001). The authors conclude that EPD permits children with food-induced hyperkinetic syndrome to eat foods that had previously been identified as responsible for their symptoms (especially chocolate, colorings, cow milk, egg, citrus, wheat, nuts and cheese). Food allergy is considered a possible mechanism of the hyperkinetic syndrome. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT:</bold> Dr. Egger also reports a beneficial effect of the hypoallergenic diet in 12 children who suffered from enuresis in association with migraine and the hyperkinetic syndrome [<xref ref-type="bibr" rid="CIT0002">2</xref>]. In an editorial Fitzwater D and Macknin ML [<xref ref-type="bibr" rid="CIT0003">3</xref>] recommend additional studies before dietary therapy can be introduced as a standard therapy for enuresis. Given the hazards of pharmacological therapy and the practical disadvantages of the alarm system, Dr. Egger&#x2019;s dietary and hyposensitization methods deserve attention. For reviews of previous articles on the hypoallergenic diet. [<xref ref-type="bibr" rid="CIT0004">4</xref>]</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stolla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome</article-title>
<source>Lancet</source>
<year>1992</year>
<month>May</month>
<day>9</day>
<volume>339</volume>
<issue>8802</issue>
<fpage>1150</fpage>
<lpage>1153</lpage>
<pub-id pub-id-type="doi">10.1016/0140-6736(92)90742-L</pub-id>
<pub-id pub-id-type="pmid">1349376</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Soothill</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Effect of diet treatment on enuresis in children with migraine or hyperkinetic behavior</article-title>
<source>Clin Pediatr</source>
<year>1992</year>
<month>May</month>
<volume>31</volume>
<issue>5</issue>
<fpage>302</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1177/000992289203100508</pub-id>
<pub-id pub-id-type="pmid">1582098</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzwater</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Macknin</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Risk/benefit ratio in enuresis therapy</article-title>
<source>Clin Pediatr</source>
<year>1992</year>
<month>May</month>
<volume>31</volume>
<issue>5</issue>
<fpage>308</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="pmid">1582099</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="book">
<person-group person-group-type="editor">
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
</person-group>
<source>Progress in Pediatric Neurology</source>
<year>1991</year>
<fpage>88</fpage>
<lpage>89</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>